|
| |
TriMark Publications
Announces Release of Its Blood Glucose Testing and Diabetes Management Report
NEW YORK, August 16, 2006TriMark Publications, a global
leader in the biotechnology, healthcare and life sciences publishing, announces
the release of its
Blood Glucose Testing and Diabetes Management report. The purpose of this
report is to describe the specific market segments of the in vitro diagnostics
market for blood glucose testing and diabetes management. This study reviews all
of the generally accepted clinical analytical methods that are currently in use
today for measuring serum or plasma or whole-blood glucose concentrations. It
examines clinical measurement devices, reagents and supplies as utilized in
hospitals, clinics, doctors offices and at-home care locations.
The emphasis in this examination is on those companies that
are actively manufacturing clinical laboratory instrumentation, self-testing
meters, point of care (POC) devices, reagents and supplies for performing blood
glucose testing to facilitate effective diabetes detection and management. The
reader should consult other TriMark Publications reports for a detailed
discussion of the important individual market segments which are related to the
POC testing (POCT) market, such as clinical chemistry, hematology and
coagulation, blood gas and electrolytes, cancer tumor markers, cytology and
immunochemistry.
The main objectives of this analysis are:
Identifying viable technology drivers through a
comprehensive look at platform technologies for glucose testing for diabetes
management.
Understanding the different sectors of glucose testing,
such as home self-testing, POCT, physician office laboratories (POL) and the
hospital market segment.
Obtaining a complete understanding of the individual
glucose testing platforms from their basic principles to their clinical
applications.
Discovering feasible market opportunities by identifying
high-growth applications in different analytical diagnostic areas.
Focusing on global industry development through an in-depth
analysis of the major world markets for glucose measurement technology,
including growth forecasts.
Presenting market figures regarding the current value of
blood glucose testing, market projections, market share, key players, and sector
growth rates.
Providing a detailed analysis of each of the major device
categories, such as blood glucose meters (including non- and
minimally-invasive), blood glucose meter test strips, lancets and lancing
devices, POC glycated hemoglobin testing products, and urine glucose/metabolite
monitoring strips.
This report defines the dollar volume of sales, both
worldwide and in the U.S. of the market, and it analyzes the factors that
influence the size and the growth of the market segments. Key questions answered
in this examination include:
How can glucose measuring tools and technologies facilitate
improved diabetes patient care?
What are the main types of glucose testing technologies
that are currently available?
Who are the current key players in this marketplace?
Which glucose testing market areas have the greatest
potential for growth?
What is the current state of the glucose testing market?
Which diagnostic companies are investing in new glucose
testing technology platform solutions?
What are the main glucose testing business strategies
adopted by leading companies?
What are the benefits of various glucose testing technology
platforms?
Additionally, this study contains:
Detailed analysis of recent trends in the glucose testing
marketplace.
In-depth profiles of the leading companies with glucose
testing tools and technologies.
Perspectives of the glucose testing industry from leading
industry experts.
Analysis of potential new glucose testing applications in
the clinical sector as they pertain to diabetes management.
Market predictions and trends analysis concerning U.S.
expenditures on glucose testing solutions.
Projections of glucose testing market sizes for U.S.,
European and Asian markets.
Projections for future applications of non-invasive tests
in glucose testing-related screening.
Review of commercial glucose testing business strategies
such as co-branding.
http://www.bioportfolio.com/cgi-bin/acatalog/Blood_Glucose_Testing_and_Diabetes_Management_Report.html
Reasons to Buy TriMark Content
Content is updated regularly in accordance with changes in
the industries our reports cover.
Content is specifically designed to help individuals who
work in the industries the content covers remain competitive in the marketplace.
Content contains detailed sales data, market share
information and emerging trends, all of which impact the sectors biotechnology,
healthcare, pharmaceutical and medical devices companies operate in.
Your competitors are buying TriMark content!
About TriMark Publications, LLC
Based in New
York City, TriMark Publications is a global leader in the biotechnology,
healthcare and life sciences publishing. Market research reports include:
TriMark Publications
Avian Influenza Report
Blood Glucose Testing and Diabetes Management Report
Clinical Chemistry Analyzers
Nutraceuticals and Dietary Supplements Markets Report
Pharmacogenomic Testing Markets
Point of Care Diagnostic Testing Sector Trends
Microarray Markets
Cytology and HPV Testing World Markets
Indian Pharmaceutical Industry
Medical Imaging Markets
Bioinformatics State of the Art
Disposable Syringes Markets
High-Growth Diagnostics Tests Markets
Microscopy Markets
Cardiac Marker Diagnostic Tests Markets
Genomics World Markets
Mammography World Markets
Cancer Diagnostic Testing World Markets
Molecular Diagnostics Markets
Point Of Care Diagnostic Testing World Markets
Diabetes, Metabolic Syndrome & Cardiovascular Disease: Reshaping Tomorrow's
Diabetes Market
Over The Counter Diagnostic Product World Markets
Important
Notice
The statements contained in this
news release that are forward-looking are based on current expectations that are
subject to a number of uncertainties and risks, and actual results may differ
materially.
| |
|
